Bayer vs BYD: Founders, CEOs and History
Bayer was founded in 1863 by Friedrich Bayer, Johann Friedrich Weskott and is led by Bill Anderson. BYD was founded in 1995 by Wang Chuanfu, Lu Xiangyang and is led by Wang Chuanfu.
Company facts
Founders
Bayer
Friedrich Bayer
Bayer was founded in 1863 in Barmen, now part of Wuppertal, Germany, by two men with complementary skills: Friedrich Bayer, a dye merchant, and Johann Friedrich Weskott, a master dyer.
Johann Friedrich Weskott
Johann Friedrich Weskott was a German master dyer who co-founded what became Bayer. In 1863 he and his friend Friedrich Bayer, a dye salesman, formed Friedr. Bayer et comp. in Barmen, now part of Wuppertal, Germany.
BYD
Wang Chuanfu
Wang Chuanfu founded BYD in Shenzhen in 1995 with his cousin Lu Xiangyang to make rechargeable batteries for mobile phones.
Lu Xiangyang
Lu Xiangyang put up the early capital when Wang Chuanfu started BYD in 1995 and has sat on BYD's board ever since, now as a non-executive director. His stake in BYD made him one of China's richest people.
CEOs and their tenures
Bayer
- Werner Wenning2002–2010
Chief Executive Officer and Chairman of the Board of Management
Wenning led Bayer from April 2002 to September 30, 2010. He took over months after the worldwide withdrawal of the cholesterol drug Baycol and spent his early years settling the claims that followed.
Source - Marijn Dekkers2010–2016
Chief Executive Officer and Chairman of the Board of Management
Dekkers was CEO from October 1, 2010 to April 30, 2016 and the first Bayer chief executive hired from outside the company. He narrowed Bayer to life sciences: in 2014 Bayer bought the consumer care business of Merck and Co.
Source - Werner Baumann2016–2023
Chief Executive Officer and Chairman of the Board of Management
Baumann became CEO in May 2016 and retired at the end of May 2023 after 35 years at Bayer. His defining decision was the acquisition of Monsanto, completed on June 7, 2018 at USD 128 per share, about USD 63 billion in total.
Source - Bill Anderson2023–present
Chief Executive Officer and Chairman of the Board of Management
Anderson, a chemical engineer who previously ran Roche's pharmaceuticals division and Genentech, joined Bayer's Board of Management on April 1, 2023 and became CEO on June 1, 2023.
Source
BYD
- Wang Chuanfu1995–present
Founder, Chairman and President (CEO)
Wang Chuanfu has run BYD since founding it in 1995. He moved the company from phone batteries into cars in 2003, launched the first mass-produced plug-in hybrid in 2008, introduced the Blade Battery in 2020 and ended combustion-only car production in 2022.
Source - Lu Xiangyang1995–present
Co-Founder and Non-Executive Director
Lu Xiangyang, Wang Chuanfu's cousin and a former banker, provided early capital for BYD in 1995 and has remained on the board, now as a non-executive director.
Source - Stella Li1996–present
Executive Vice President; CEO of BYD Americas and Europe
Stella Li joined BYD in September 1996 as a marketing manager for exports, opened its first overseas office in Hong Kong in 1997 and set up its European headquarters in 1999.
Source
Timeline: Bayer and BYD side by side
1863Bayer
Bayer Founded in Barmen, Germany
Friedrich Bayer and Johann Friedrich Weskott entered Friedrich Bayer et. Compagnie into the commercial register in Barmen, Germany, on August 1, 1863, to make synthetic fuchsine and aniline dyes for the textile industry using the new coal-tar chemistry.
1898Bayer
Heroin Marketed as a Cough Suppressant
Bayer began selling diacetylmorphine under the trademark Heroin as a cough suppressant and a supposedly non-addictive substitute for morphine. It stayed in Bayer's range until after World War I, long after its addictiveness was understood.
1899Bayer
Aspirin Registered as a Trademark
The Bayer chemist Felix Hoffmann had synthesized acetylsalicylic acid in a stable, pure form in 1897, and Bayer registered the trademark Aspirin on March 6, 1899. It became the first mass-market synthetic medicine and is still one of the most widely used.
1903Bayer
Veronal Barbiturate Sleep Aid Launched
Bayer licensed diethylbarbituric acid from Emil Fischer and Joseph von Mering and sold it as Veronal, the first barbiturate sleep aid.
1912Bayer
Headquarters Moved to Leverkusen
Under Carl Duisberg, Bayer moved its main chemical plant and head office to Leverkusen on the Rhine, building one of the largest industrial chemical sites in Europe. Leverkusen is still the group headquarters.
1918Bayer
US Assets Confiscated During World War I
Bayer's US assets and trademarks, including the Aspirin trademark, were confiscated by the Alien Property Custodian and sold to Sterling Products. Bayer lost its largest export market and the right to its own name in North America for decades.
1925Bayer
Merger into IG Farben
Bayer merged with BASF, Hoechst, Agfa and other German chemical companies to form IG Farbenindustrie AG, then the largest chemical and pharmaceutical group in the world. IG Farben's role in the Nazi war effort led the Allies to dissolve it after World War II.
1932Bayer
Prontosil Discovered by Gerhard Domagk
Gerhard Domagk, leading a research team in the Bayer laboratories, developed Prontosil, the first sulfonamide antibacterial and the forerunner of modern antibiotics. He was awarded the Nobel Prize in Physiology or Medicine in 1939 for the work.
1951Bayer
Re-established After the IG Farben Dissolution
Bayer was reincorporated as Farbenfabriken Bayer AG in 1951 after the Allied dissolution of IG Farben and rebuilt as an independent chemical and pharmaceutical company during West Germany's post-war recovery.
1994Bayer
US Bayer Trademark Rights Reclaimed
Bayer bought Sterling Winthrop's over-the-counter drug business from SmithKline Beecham for about USD 1 billion, recovering the US and Canadian rights to the Bayer name and the Bayer Cross confiscated in 1918, plus the Aspirin trademark in Canada.
1995BYD
BYD founded in Shenzhen
Wang Chuanfu and his cousin Lu Xiangyang start BYD in Shenzhen with about 20 employees, making rechargeable batteries for mobile phones.
2000BYD
Becomes a leading NiCd battery maker
BYD becomes one of the world's largest makers of nickel-cadmium batteries, supplying major electronics brands.
2001Bayer
Baycol Withdrawn Worldwide
Bayer voluntarily withdrew its cholesterol drug Baycol, sold as Lipobay outside the United States, in August 2001 after cases of fatal rhabdomyolysis, particularly at higher doses and in combination with gemfibrozil.
2002BYD
Hong Kong listing
BYD lists its H shares on the Hong Kong Stock Exchange under stock code 1211.
2003BYD
Buys Qinchuan and enters the car business
BYD acquires a controlling stake in Xi'an Qinchuan Automobile for about $37.4 million (CN¥269 million), gaining a car production licence and factory.
2006Bayer
Schering AG Acquired for About EUR 17 Billion
Bayer acquired Schering AG of Berlin for about $19.2 billion (EUR 17 billion) after counter-bidding against a hostile approach from Merck KGaA, adding the Mirena contraceptive franchise, oncology assets and a European pharmaceutical sales force.
2008BYD
Berkshire Hathaway takes about 10%
Berkshire Hathaway's MidAmerican Energy invests $232 million for about 10% of BYD, giving the company international credibility.
2008BYD
Launches the F3DM plug-in hybrid
BYD launches the F3DM, the world's first mass-produced plug-in hybrid car, two years before the Chevrolet Volt.
2010BYD
Denza joint venture with Daimler
BYD and Daimler set up Denza as a 50:50 joint venture to build premium electric cars in China.
2011BYD
Launches the e6 and lists in Shenzhen
BYD launches the e6 electric crossover, first used as a taxi in Shenzhen, and lists A shares on the Shenzhen Stock Exchange (002594).
2014Bayer
Merck Consumer Care Acquired for USD 14.2 Billion
Bayer closed the purchase of the consumer care business of Merck and Co. on October 1, 2014 for USD 14.2 billion in cash, adding Claritin, Coppertone and Dr. Scholl's and making Bayer one of the largest non-prescription medicine companies in the world.
2015Bayer
Covestro Spin-off
Bayer listed its materials science division as Covestro through an IPO on the Frankfurt Stock Exchange, ending its presence in plastics and polymers and leaving a group focused on pharmaceuticals, consumer health and crop science.
2018Bayer
Monsanto Acquisition Completed for About USD 63 Billion
Bayer completed the acquisition of Monsanto on June 7, 2018, paying USD 128 per share, about USD 63 billion in total, the largest foreign acquisition by a German company.
2020Bayer
USD 10.9 Billion Roundup Settlement
Bayer agreed to pay about USD 10.9 billion to settle roughly 113,000 Roundup claims while continuing to maintain that glyphosate does not cause cancer. The programme did not end the litigation and new claims kept arriving.
2020BYD
Launches the Blade Battery
BYD introduces the Blade Battery, an LFP cell-to-pack design that passes the nail penetration test without fire.
2022BYD
Ends combustion-only car production
In March 2022 BYD stops making combustion-only passenger cars and focuses entirely on battery EVs and plug-in hybrids.
2023Bayer
Bill Anderson Becomes CEO
Werner Baumann retired at the end of May 2023 after 35 years at Bayer. Bill Anderson, previously head of Roche's pharmaceuticals division and of Genentech, joined the Board of Management in April and became CEO on June 1, 2023.
2023BYD
Passes Tesla in quarterly BEV sales
BYD sells 3.02 million new energy vehicles in 2023, and its 526,409 battery EVs in the fourth quarter top Tesla's 484,507 for the first time in a quarter.
2024Bayer
Dynamic Shared Ownership Rolled Out
Bayer began introducing the Dynamic Shared Ownership operating model, replacing layers of middle management with self-directed teams.
2024BYD
Takes full ownership of Denza
Mercedes-Benz sells its last 10% of Denza in July 2024, leaving BYD as the sole shareholder of its premium brand.
2025Bayer
Nubeqa Approved in the US for Metastatic Castration-Sensitive Prostate Cancer
The FDA approved Nubeqa (darolutamide) in June 2025 for metastatic castration-sensitive prostate cancer, a third indication, followed by EU authorization in July 2025.
2025BYD
Berkshire Hathaway exits
Berkshire Hathaway confirms in September 2025 that it has sold its entire BYD stake, ending a 17-year investment.
2025BYD
Becomes the world's top battery EV seller
BYD sells 2.26 million battery EVs in 2025 against Tesla's 1.64 million, and 4.6 million new energy vehicles in total.
2026Bayer
Supreme Court Preemption Ruling and Proposed USD 7.25 Billion Roundup Class Settlement
In February 2026 Monsanto proposed a US nationwide class settlement funded by declining annual payments of up to USD 7.25 billion over as long as 21 years, which received preliminary approval in March 2026.
2026BYD
Unveils Blade Battery 2.0 and FLASH charging
On March 5, 2026 BYD unveils the second-generation Blade Battery, which charges from 10% to 70% in about five minutes, and plans 20,000 FLASH charging stations in China by the end of 2026.
2026BYD
Overseas revenue passes China
In the first half of 2026 BYD's overseas revenue of ~$25.2 billion (CN¥181.3 billion) exceeds revenue from China for the first time, even as group revenue falls 7.1% to ~$47.9 billion (CN¥344.8 billion).
Acquisitions
Bayer
- Monsanto Company2018$63B
- Merck Consumer Care2014$14.2B
- Schering AG2006$21.2B
- Sterling Winthrop OTC Business1994$1B
BYD
- Denza (remaining stake from Mercedes-Benz)2024Undisclosed
- Jabil mobile electronics manufacturing business (China)2023$2B
- Xi'an Qinchuan Automobile2003$32M
Questions about Bayer vs BYD
Who is the CEO of Bayer AG and BYD Company Ltd?
Bayer AG is led by Bill Anderson and BYD Company Ltd is led by Wang Chuanfu. Both serve as the top executive responsible for the company's strategy, operations, and financial performance.
When was Bayer AG founded vs BYD Company Ltd?
Bayer AG was founded in 1863 — 132 years before BYD Company Ltd, which was founded in 1995. Bayer AG's longer operating history gives it a deeper track record but also potentially more institutional inertia compared to the younger BYD Company Ltd.
How many employees does Bayer AG have compared to BYD Company Ltd?
Bayer AG employs approximately 88,078 people, while BYD Company Ltd employs approximately 911,900. BYD Company Ltd has the larger workforce at 911,900 employees, compared to Bayer AG's 88,078. A higher headcount does not necessarily imply greater efficiency — it often reflects differences in business model (e.g., manufacturing vs. software).
Where are Bayer AG and BYD Company Ltd headquartered?
Bayer AG is headquartered in Germany and BYD Company Ltd is headquartered in China. Their different home markets mean they may face different regulatory frameworks, tax regimes, and currency exposure.
Who founded Bayer AG and BYD Company Ltd?
Bayer AG was founded by Friedrich Bayer, Johann Friedrich Weskott. BYD Company Ltd was founded by Wang Chuanfu, Lu Xiangyang.
Which company has a longer operating history — Bayer AG or BYD Company Ltd?
Bayer AG has been operating for approximately 163 years, making it the more established of the two companies. BYD Company Ltd has been in operation for around 31 years. A longer operating history often signals greater institutional resilience and brand recognition, though it can also mean slower adaptation to new market conditions.
Figures come from each company's filings and the sources linked beside them. Amounts reported in another currency are shown in US dollars at an approximate rate and marked with ~. Back to the Bayer vs BYD overview